Browse Data and Analysis

Colombia’s agricultural industry widely utilizes innovative biotechnologies, and its regulatory environment remains open genetically engineered (GE) derived commodities. However, congressional anti-biotechnology initiatives continue to risk undoing decades of scientific advancement, undermining biotechnology development and potentially impacting agricultural trade.